RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+18.42%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.87B
AUM Growth
+$1.87B
(+21%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
7.35%
Top 10 Holdings %
Top 10 Hldgs %
73.27%
Holding
30
New
3
Increased
7
Reduced
1
Closed
4
Top Buys
| 1 |
Arvinas
ARVN
|
$52.9M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$48.7M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$36.4M |
| 4 |
TG Therapeutics
TGTX
|
$21.9M |
| 5 |
PGNX
Progenics Pharmaceuticals Inc
PGNX
|
$19M |
Top Sells
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$56.4M |
| 2 |
Clearside Biomedical
CLSD
|
$16.3M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$11.4M |
| 4 |
Spero Therapeutics
SPRO
|
$10.9M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$1.74M |
Sector Composition
| 1 | Healthcare | 93.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Protara Therapeutics
TARA
$120M
| $2.61M | 0.14% | 1,337,462 | – | – |
|
|
27
Clearside Biomedical
CLSD
$28.9M
| – | – | -1,525,000 | Closed | -$16.3M |
|
|
28
Spero Therapeutics
SPRO
$116M
| – | – | -741,647 | Closed | -$10.9M |
|
|
GTHX
29
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – | -40,000 | Closed | -$1.74M |
|
|
AVEO
30
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| – | – | -5,062,759 | Closed | -$11.4M |
|